Sabina Signoretti

机构：Broad Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute · ORCID：0000-0002-5000-9105

发表论文 1229 篇 · 总被引 92896 次 · h-index 131

代表论文

Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma (2026 · Nature Communications · 被引 1)
8 Single Cell Transcriptomic Investigation of Renal Cell Carcinoma (RCC) Reveals Tissue Resident Memory Exhausted CD8+ T Cell Signature Associated with Resistance to Immune Checkpoint Inhibition (ICI) (2026 · The Oncologist)
51 Discovery of Exhausted CD8+ T-cell States Associated with Clinical Outcomes in Renal Cell Carcinoma (2026 · The Oncologist)
70 Lymphocyte Hsp70 is a Novel Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma (2026 · The Oncologist)
Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation (2026 · Journal of Clinical Investigation)
Supplementary Table S9 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial (2026)